Compare WSR & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WSR | INMD |
|---|---|---|
| Founded | 1998 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 974.9M | 842.0M |
| IPO Year | 2002 | 2018 |
| Metric | WSR | INMD |
|---|---|---|
| Price | $18.96 | $14.60 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 5 |
| Target Price | ★ $19.00 | $17.33 |
| AVG Volume (30 Days) | 677.0K | ★ 743.8K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.01% | N/A |
| EPS Growth | ★ 31.94 | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $160,859,000.00 | N/A |
| Revenue This Year | $2.77 | $1.74 |
| Revenue Next Year | $4.21 | $3.26 |
| P/E Ratio | $237.00 | ★ $10.11 |
| Revenue Growth | ★ 4.26 | N/A |
| 52 Week Low | $11.43 | $12.72 |
| 52 Week High | $19.10 | $16.74 |
| Indicator | WSR | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.24 | 64.01 |
| Support Level | $18.90 | $14.58 |
| Resistance Level | $19.01 | $14.71 |
| Average True Range (ATR) | 0.03 | 0.25 |
| MACD | -0.03 | 0.16 |
| Stochastic Oscillator | 27.50 | 70.96 |
Whitestone REIT is a real estate investment trust (REIT) that owns and operates commercial properties in culturally diverse metropolitan markets. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business-friendly locations in and around Austin, Scottsdale, Dallas, Houston, Phoenix, Arizona, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.